AstraZeneca advances plan for climate-friendly inhalers

Pharmaceutical giant is partnering with Honeywell to develop an inhaler propellant that has 99.9 percent less Global Warming Potential than current models. Read More

4 takeaways from GreenBiz 22

At GreenBiz's flagship annual conference, corporate leaders highlighted these focus areas, from investor engagement to net zero. Read More

Vanguard takes a baby step on climate change — finally

The $7 trillion silent member of the Big Three tags coal as a concern years behind other investors. Read More

Confronting the reality of inequitable access to recycling

Will investing in research, infrastructure and training improve the system? Read More

21 solutions to make our economy more circular

Instead of producing more things, we must maximize the use of existing ones. Read More

Climate change-fueled floods could cause 26% more damage in next 30 years

The annual cost of flooding today is over US$32 billion nationwide, with an outsized burden on communities in Appalachia, the Gulf Coast and the Northwest. Read More

Across the boreal forest, scientists are tracking warming’s tragic toll

Thawing permafrost, drowned trees, methane releases and increased wildfires, are slowly transforming Northern Forests from carbon sinks to carbon emitters. Read More

Carbon tunnel vision leads to missed opportunities in water

With all the focus on carbon, what are corporations doing on water? Read More

3 lessons from hosting our first mostly vegan conference

How did our attendees like our vegan menu? And what did we would we change for next time? Read More

Is the food sector moving away from carbon offsetting?

At GreenBiz 22, sustainability leaders talked about how carbon credits will play a role in their sustainability strategies. Read More